作者：
John H,Farley [1]
;
William E,Brady [2]
;
David,O'Malley [3]
;
Keiichi,Fujiwara [4]
;
Kan,Yonemori [5]
;
Albert,Bonebrake [6]
;
Angeles Alvarez,Secord [7]
;
Jean-Marie,Stephan [8]
;
Joan L,Walker [9]
;
Joo-Hyun,Nam [10]
;
Michael J,Birrer [11]
;
David M,Gershenson [12]
作者单位：
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. Electronic address: John.farley@chw.edu.
[1]
NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
[2]
The Ohio State University, Columbus, OH, USA. Electronic address: omalley.46@osu.edu.
[3]
Saitama Medical University International Medical Center, Japan. Electronic address: fujiwara@saitama-med.ac.jp.
[4]
National Cancer Center Hospital, 5 Chome-1 - 1 Tsukiji, Chuo City, Tokyo 104-0045, Japan. Electronic address: kyonemor@ncc.go.jp.
[5]
Cancer Research for the Ozarks-Cox Health, Springfield, MO, USA. Electronic address: albert.bonebrake@coxhealth.com.
[6]
Duke University Medical Center, Durham, NC, USA. Electronic address: secor002@mc.duke.edu.
[7]
Rush University Medical Center, Chicago, IL 60612, USA. Electronic address: Jean-Marie_Stephan@rush.edu.
[8]
University of Oklahoma, Oklahoma City, OK 73104, USA. Electronic address: joan-walker@ouhsc.edu.
[9]
Asan Medical Center, University of Ulsan, Seoul 13876 05505, KR, Republic of Korea. Electronic address: jhnam@amc.seoul.kr.
[10]
Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: mbirrer@uab.edu.
[11]
Dept. of Gynecologic Oncology, University of Texas, MD, USA; Anderson Cancer Center, Unit 1362, PO Box 301439, Houston, TX 77230-1439, USA. Electronic address: dgershen@mdanderson.org.
[12]
DOI
10.1016/j.ygyno.2022.10.006
PMID
36244829
发布时间
2023-12-22
换一批
换一批
